Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer

Phase 1/2 Withdrawn Jonsson Comprehensive Cancer Center

NaSingle-groupOpen-labelTreatment

Summary

This phase Ib/II trial studies the side effects of near-infrared image guided surgical resection with indocyanine green in treating patients with head and neck cancer. Near-infrared image guided surgical resection with indocyanine green may make it easier to find and remove tumors.

Timeline

Start: 2018-12-12
Primary completion: 2021-06-08
Completion: 2021-06-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Indocyanine Green	Diagnostic / imaging agent	—	Intravenous

Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer

Summary

Timeline

Drugs

Indications